Cello Group (CLL)
CLL Share PerformanceMore
|52 week high||140.00 11/05/17|
|52 week low||94.50 08/11/16|
|52 week change||26.00 (26.53%)|
|4 week volume||604,462 02/07/17|
Latest News« previous» nextMore
19/07/2017 - 07:23 StockMarketWire
Cello Group said it had a good first half with particularly strong overall and like-for-like growth from Cello Health. A pre...
19/07/2017 - 07:00 RNS
RNS Number: 4256L Cello Group plc 19 July 2017 For Immediate Release 19 July 2017 Cello Group plc ('Cello' or the 'Group') Pre Close Trading Statement Cello Group plc (AIM:CLL), the healthcare and strategic marketing group, today publishes the following update for the six months to 30 June 2017. The Group has had a good first half of the year, with particularly st...
18/07/2017 - 07:27 StockMarketWire
Cello Group has acquired the assets of Advantage Healthcare. Cello said the proposed initial consideration for the acquisitio...
18/07/2017 - 07:00 RNS
RNS Number: 3065L Cello Group plc 18 July 2017 For Immediate Release 18 July 2017 Cello Group plc Acquisition of Advantage Healthcare Inc Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company), the healthcare and strategic marketing group , is pleased to announce the acquisition of the assets of Advantage Healthcare Inc ("Advantage Healthcare"). Th...
30/06/2017 - 12:31 RNS
RNS Number: 7629J Cello Group plc 30 June 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 30 June 2017 Cello's issued share capital consists of 104,122,969 ordinary shares of 10 pence each ("Ordinary Shares"). The Company holds 453,...
23/06/2017 - 12:23 RNS
RNS Number: 0339J Cello Group plc 23 June 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii CELLO GROUP PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition...
14/06/2017 - 11:33 RNS
RNS Number: 0762I Cello Group plc 14 June 2017 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has received notification that on 13 June 2017, Barney Hosey, a director of Cello Signal, exercised share options over 20,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at an exercise price of 50 pence per...
31/05/2017 - 10:27 RNS
RNS Number: 6893G Cello Group plc 31 May 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 May 2017 Cello's issued share capital consists of 104,101,277 ordinary shares of 10 pence each ("Ordinary Shares"). The Company holds 453,0...
|Dividend yield||2.742 %|
Latest discussion posts More
“Don't know what to make of the pre-close trading update: Health's doing well, but mixed signals from Signal. Could have done with a bit more meat on the bone, especially ...”▼
“Wow, that's two 250 trades gone through, and the sp holds steady - up now. Hmm, glad I'm holding. Maybe that should have been a Buy rec...”▼
“Just as well I wasn't expecting anything too dramatic ;). Everything seems to be ticking along nicely. Seems like they''ve decided that they need to grow by acquisition. ...”▼
Codes & Symbols
|Symbols||CLL, LSE:CLL, CLL.L, CLL:LN, LON:CLL, XLON:CLL|